Rentosertib IND Cleared for Inhalation Study in IPF — AI-Discovered by Insilico
Insilico’s AI-discovered Rentosertib (ISM001-055) wins IND for inhalation Phase I in IPF, validating Pharma.AI’s faster, repeatable drug discovery approach.
Rentosertib IND Cleared for Inhalation Study in IPF — AI-Discovered by Insilico Read More »










